z-logo
open-access-imgOpen Access
MP06-17 GEMCITABINE PLUS PACLITAXEL AS THIRD LINE CHEMOTHERAPY: A FEASIBLE OPTION FOR METASTATIC UROTHELIAL CARCINOMA PATIENTS
Author(s) -
Taku Naiki,
Keitaro Iida,
Ryosuke Ando,
Toshiki Etani,
Noriyasu Kawai,
Takashi Nagai,
Yosuke Sugiyama,
Masahiro Kondo,
T. Okamura,
Takahiro Yasui
Publication year - 2016
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2016.02.2178
Subject(s) - gemcitabine , medicine , oncology , chemotherapy , docetaxel , urothelial carcinoma , metastatic urothelial carcinoma , paclitaxel , cancer , bladder cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom